Literature DB >> 19095983

Novel LMNA mutation in atypical Werner syndrome presenting with ischemic disease.

Dimitri Renard1, Genevieve Fourcade, Didier Milhaud, Didier Bessis, Vera Esteves-Vieira, Amandine Boyer, Patrice Roll, Patrice Bourgeois, Nicolas Levy, Annachiara De Sandre-Giovannoli.   

Abstract

BACKGROUND AND
PURPOSE: Laminopathies arise through mutations in genes encoding Lamin A/C (LMNA) or associated proteins. They cause 4 different groups of disorders with diverse severity and often overlapping features: diseases of striated muscle (leading to muscular or cardiac involvement), peripheral neuropathy, lipodystrophy syndromes, and accelerated aging disorders. SUMMARY OF CASE: We report on a familial case of atypical Werner syndrome (a progeroid syndrome with Werner syndrome phenotype but without typical RECQL2 mutation) presenting with acute ischemic cerebral disease or peripheral artery disease associated with diffuse atherosclerosis, attributable to transmission of a novel LMNA mutation.
CONCLUSIONS: In young patients with ischemic events and a positive family history, other progeroid features have to be searched and LMNA testing has to be considered, allowing for genetic counseling and presymptomatic testing of at-risk relatives.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095983     DOI: 10.1161/STROKEAHA.108.531780

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  14 in total

Review 1.  Inner nuclear membrane proteins: impact on human disease.

Authors:  Iván Méndez-López; Howard J Worman
Journal:  Chromosoma       Date:  2012-02-04       Impact factor: 4.316

Review 2.  Diseases of the Nucleoskeleton.

Authors:  James M Holaska
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

3.  Early onset mandibuloacral dysplasia due to compound heterozygous mutations in ZMPSTE24.

Authors:  Zahid Ahmad; Elaine Zackai; Livija Medne; Abhimanyu Garg
Journal:  Am J Med Genet A       Date:  2010-11       Impact factor: 2.802

4.  Pancreatic Histopathology of Human Monogenic Diabetes Due to Causal Variants in KCNJ11, HNF1A, GATA6, and LMNA.

Authors:  May Sanyoura; Laura Jacobsen; David Carmody; Daniela Del Gaudio; Gorka Alkorta-Aranburu; Kelly Arndt; Ying Hu; Frances Kobiernicki; Irina Kusmartseva; Mark A Atkinson; Louis H Philipson; Desmond Schatz; Martha Campbell-Thompson; Siri Atma W Greeley
Journal:  J Clin Endocrinol Metab       Date:  2018-01-01       Impact factor: 5.958

Review 5.  Roles of Werner syndrome protein in protection of genome integrity.

Authors:  Marie L Rossi; Avik K Ghosh; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2010-01-13

6.  Atypical progeroid syndrome due to heterozygous missense LMNA mutations.

Authors:  Abhimanyu Garg; Lalitha Subramanyam; Anil K Agarwal; Vinaya Simha; Benjamin Levine; Maria Rosaria D'Apice; Giuseppe Novelli; Yanick Crow
Journal:  J Clin Endocrinol Metab       Date:  2009-10-29       Impact factor: 5.958

7.  LMNA-associated cardiocutaneous progeria: an inherited autosomal dominant premature aging syndrome with late onset.

Authors:  Megan S Kane; Mark E Lindsay; Daniel P Judge; Jemima Barrowman; Colette Ap Rhys; Lisa Simonson; Harry C Dietz; Susan Michaelis
Journal:  Am J Med Genet A       Date:  2013-05-10       Impact factor: 2.802

Review 8.  MicroRNAs in hereditary and sporadic premature aging syndromes and other laminopathies.

Authors:  Diane Frankel; Valérie Delecourt; Karim Harhouri; Annachiara De Sandre-Giovannoli; Nicolas Lévy; Elise Kaspi; Patrice Roll
Journal:  Aging Cell       Date:  2018-04-25       Impact factor: 9.304

Review 9.  Molecular insights into the premature aging disease progeria.

Authors:  Sandra Vidak; Roland Foisner
Journal:  Histochem Cell Biol       Date:  2016-02-04       Impact factor: 4.304

10.  Dupuytren's and Ledderhose Diseases in a Family with LMNA-Related Cardiomyopathy and a Novel Variant in the ASTE1 Gene.

Authors:  Michael V Zaragoza; Cecilia H H Nguyen; Halida P Widyastuti; Linda A McCarthy; Anna Grosberg
Journal:  Cells       Date:  2017-11-01       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.